Added to YB: 2025-09-09
Pitch date: 2025-07-23
DGX [bullish]
Quest Diagnostics Incorporated
+15.31%
current return
Author Info
No bio for this author
Company Info
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
Market Cap
$21.8B
Pitch Price
$170.99
Price Target
230.00 (+18%)
Dividend
1.73%
EV/EBITDA
10.46
P/E
22.70
EV/Sales
2.55
Sector
Health Care Providers and Services
Category
growth
Quest Diagnostics Incorporated - $DGX
DGX: Duopoly w/ LabCorp in clinical testing serving 50% hospitals, 33% US adults. Trades cheap despite recurring revenue from chronic disease tailwinds & early detection trends. 2026 est: $11.2B revenue, $2.3B EBITDA, $1.2B FCF. EPS $10.50+ by 2026, $11.50+ 2027. 20x P/E = $230 target. Catalysts: unhealthier population driving test demand.
Read full article (4 min)